Derivation of cutoffs for the Elecsys(®) amyloid β (1–42) assay in Alzheimer's disease

INTRODUCTION: An Elecsys® Amyloid β (Aβ [1–42]) immunoassay cutoff for classification of patients with Alzheimer's disease was investigated. METHODS: Cerebrospinal fluid samples collected from patients with mild-to-moderate Alzheimer's disease were analyzed by Elecsys® immunoassays: (1) Aβ...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Alzheimers Dement (Amst)
Huvudupphovsmän: Shaw, Leslie M., Waligorska, Teresa, Fields, Leona, Korecka, Magdalena, Figurski, Michal, Trojanowski, John Q., Eichenlaub, Udo, Wahl, Simone, Quan, Marian, Pontecorvo, Michael J., Lachno, D. Richard, Talbot, Jayne A., Andersen, Scott W., Siemers, Eric R., Dean, Robert A.
Materialtyp: Artigo
Språk:Inglês
Publicerad: Elsevier 2018
Ämnen:
CSF Biomarkers
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6222032/
https://ncbi.nlm.nih.gov/pubmed/30426066
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.dadm.2018.07.002
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk